LONDON - The FTSE 100 slid from 13-year peaks on Thursday, battered by weak Chinese economic data and signs the U.S. Federal Reserve could soon taper its stimulus programme.
FRANKFURT - New solar installations reached a fresh record of 7.5 gigawatts (GW) in Germany in 2011, playing into the hands of advocates for steeper cuts in tariff subsidies to reduce growth of solar power and the resulting higher costs for consumers.
Illumina says Complete Genomics rejects buyout offer
(Reuters) - Genetic sequencing company Illumina Inc (ILMN.O) said smaller peer Complete Genomics Inc GNOM.O rejected its takeover bid of about $114 million.
Complete Genomics had agreed to be bought by China's BGI-Shenzhen in September for $3.15 per share, three months after the gene sequencing company started a strategic review.
Illumina on Friday revealed its bid of $3.30 per Complete Genomics share.
In a filing on Wednesday, Illumina said its bid was superior and unlike the BGI bid, was not contingent on financing or subject to government approval as a foreign investment.
Shares of Illumina closed at $50.52 on Tuesday, while those of Complete Genomics closed at $3.09 on the Nasdaq.
(Reporting by Balaji Sridharan in Bangalore; Editing by Supriya Kurane)
- Tweet this
- Share this
- Digg this